| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | VZ | United States | $46.94 | $138,191,000,000.00 | Buy | 15 | 2000 |
#2 | T | United States | $27.08 | $125,648,000,000.00 | Buy | 20 | N/A |
#3 | SNY | France | $48.28 | $54,850,299,422.00 | Buy | 6 | N/A |
#4 | BN | Canada | $46.90 | $76,933,000,000.00 | Strong Buy | 7 | N/A |
#5 | CMCSA | United States | $31.64 | $123,707,000,000.00 | Buy | 19 | 1972 |
#6 | NU | Brazil | $17.53 | $6,360,698,000.00 | Buy | 9 | 2021 |
#7 | EPD | United States | $35.18 | $52,596,000,000.00 | Buy | 13 | 1998 |
#8 | CSX | United States | $40.73 | $14,092,000,000.00 | Buy | 21 | N/A |
#9 | KMI | United States | $31.03 | $16,937,000,000.00 | Buy | 12 | 2011 |
#10 | AMX | Mexico | $22.19 | $51,012,503,011.00 | Buy | 6 | 2001 |
#11 | VALE | Brazil | $16.80 | $40,027,019,862.00 | Buy | 8 | N/A |
#12 | ET | United States | $18.04 | $79,757,000,000.00 | Buy | 11 | 2006 |
#13 | WBD | United States | $27.22 | $37,863,000,000.00 | Buy | 21 | N/A |
#14 | CMG | United States | $39.53 | $11,925,601,000.00 | Buy | 28 | 2006 |
#15 | EXC | United States | $43.98 | $24,317,000,000.00 | Buy | 13 | N/A |
#16 | CUK | United States | $32.60 | $26,622,000,000.00 | Strong Buy | 20 | 2000 |
#17 | JD | China | $28.01 | $183,136,729,092.00 | Buy | 10 | 2014 |
#18 | MDLN | United States | $47.26 | $27,429,000,000.00 | Strong Buy | 23 | 2025 |
#19 | KDP | United States | $28.51 | $16,174,000,000.00 | Buy | 17 | 1993 |
#20 | KGC | Canada | $33.93 | $6,443,900,000.00 | Strong Buy | 5 | N/A |
#21 | PCG | United States | $16.36 | $24,762,000,000.00 | Buy | 9 | N/A |
#22 | CCL | United States | $32.83 | $26,622,000,000.00 | Strong Buy | 20 | 1987 |
#23 | SOFI | United States | $21.35 | $3,583,035,000.00 | Buy | 15 | N/A |
#24 | KVUE | United States | $18.18 | $15,006,000,000.00 | Buy | 12 | 2023 |
#25 | VICI | United States | $29.04 | $3,969,078,000.00 | Buy | 14 | N/A |
#26 | CPNG | United States | $18.55 | $33,664,000,000.00 | Strong Buy | 5 | 2021 |
#27 | TEVA | Israel | $34.46 | $17,258,000,000.00 | Strong Buy | 8 | N/A |
#28 | HBAN | United States | $19.03 | $7,703,000,000.00 | Buy | 17 | N/A |
#29 | HAL | United States | $34.94 | $22,184,000,000.00 | Buy | 16 | N/A |
#30 | FE | United States | $46.87 | $14,283,000,000.00 | Buy | 15 | N/A |
#31 | TME | China | $16.31 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#32 | CNP | United States | $40.24 | $9,114,000,000.00 | Buy | 12 | N/A |
#33 | STM | Netherlands | $32.56 | $11,800,000,000.00 | Buy | 6 | 1994 |
#34 | PPL | United States | $35.69 | $8,979,000,000.00 | Buy | 8 | N/A |
#35 | DVN | United States | $43.49 | $16,554,000,000.00 | Buy | 20 | N/A |
#36 | KEY | United States | $23.03 | $7,007,000,000.00 | Buy | 14 | N/A |
#37 | VIV | Brazil | $15.30 | $10,989,199,704.00 | Buy | 4 | 1998 |
#38 | AMCR | Switzerland | $48.47 | $19,609,000,000.00 | Strong Buy | 7 | N/A |
#39 | SW | Ireland | $44.03 | $31,138,000,000.00 | Strong Buy | 11 | N/A |
#40 | TS | Luxembourg | $47.47 | $11,831,250,000.00 | Buy | 4 | N/A |
#41 | BEKE | China | $18.72 | $14,540,474,652.00 | Strong Buy | 5 | 2020 |
#42 | CTRA | United States | $30.40 | $6,666,000,000.00 | Buy | 15 | 1990 |
#43 | NI | United States | $44.49 | $6,327,100,000.00 | Buy | 9 | N/A |
#44 | GMAB | Denmark | $30.86 | $3,845,670,022.00 | Strong Buy | 6 | N/A |
#45 | GRAB | Singapore | $4.26 | $3,228,000,000.00 | Strong Buy | 4 | N/A |
#46 | PINS | United States | $20.14 | $4,056,550,000.00 | Buy | 27 | 2019 |
#47 | TOST | United States | $28.67 | $5,858,000,000.00 | Buy | 23 | 2021 |
#48 | TTD | United States | $27.03 | $2,790,505,000.00 | Buy | 36 | 2016 |
#49 | APG | United States | $44.80 | $7,655,000,000.00 | Strong Buy | 8 | N/A |
#50 | ZTO | China | $24.13 | $6,673,175,085.00 | Strong Buy | 4 | 2016 |
The FinQuota filters have identified what they believe to be the "Best Blue Chip Stocks Under $50 (February 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.